|1.||Gomez-Mancilla, Baltazar: 3 articles (10/2013 - 07/2011)|
|2.||Grégoire, Laurent: 3 articles (10/2013 - 07/2011)|
|3.||Di Paolo, Thérèse: 3 articles (10/2013 - 07/2011)|
|4.||Morissette, Marc: 3 articles (10/2013 - 07/2011)|
|5.||Gasparini, Fabrizio: 3 articles (10/2013 - 07/2011)|
|6.||Morin, Nicolas: 2 articles (10/2013 - 03/2013)|
|7.||Gardus, J: 1 article (01/2015)|
|8.||Gomez-Mancilla, B: 1 article (01/2015)|
|9.||Behrje, R: 1 article (01/2015)|
|10.||Kumar, J S D: 1 article (01/2015)|
|1.||Cocaine-Related Disorders (Cocaine Addiction)
01/15/2014 - "The results of the study showed that cocaine addiction was associated with a 20% to 22% reduction in [(11)C]ABP688 binding in the striatum. "
01/15/2014 - "Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy."
01/01/2014 - "The temporal and spatial changes in mGluR5 availability suggest [11C]ABP688 PET imaging in epilepsy provide abnormal glutamatergic network during epileptogenesis."
01/01/2014 - "In this study, we monitored the changes of mGluR5 in vivo using [11C]ABP688 PET during the epileptogenesis in a pilocarpine-induced epilepsy rat model. "
01/01/2014 - "In vivo imaging of mGluR5 using [11C]ABP688 microPET/CT could successfully reveal the regional changes of mGluR5 binding potential of the rat brain in a pilocarpine-induced epilepsy model. "
01/01/2014 - "In vivo mGluR5 images were acquired using [11C]ABP688 microPET/CT in pilocarpine-induced chronic epilepsy rat models and controls. "
01/01/2014 - "In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model."
07/01/2011 - "PD patients with motor complications (either dyskinesias or wearing-off) had higher [(3)H]ABP688 specific binding compared to those without motor complications and controls in putamen, external and internal globus pallidus. "
03/01/2013 - "Mean dyskinesia scores of MPTP-lesioned monkeys correlated positively with [(3)H]ABP688 specific binding in the putamen. "
10/01/2013 - "The basal ganglia [(3)H]ABP688 specific binding (mGlu5 receptors) was elevated in L-DOPA-treated MPTP monkeys compared to controls but not in those treated with L-DOPA and MPEP; dyskinesia scores of these monkeys correlated positively with their [(3)H]ABP688 specific binding. "
07/01/2011 - "In 16 monkeys with a bilateral MPTP lesion and four controls, [(3)H]ABP688 specific binding was elevated in the striatum of dyskinetic l-dopa-treated MPTP monkeys but not in MPTP monkeys without dyskinesias compared to controls. "
07/01/2011 - "Using the selective mGluR5 ligand [(3)H]ABP688 autoradiography, we measured mGluR5 in brain slices from 11 normal and 14 PD patients and from MPTP monkeys, in relation to motor complications (dyskinesias and wearing-off) associated with treatment with l-dopa. "
|4.||Major Depressive Disorder (Major Depressive Disorders)
|5.||Brain Diseases (Brain Disorder)
|1.||metabotropic glutamate receptor 5
|3.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|4.||Glutamic Acid (Glutamate)
|5.||Levodopa (L Dopa)